Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

HTMD

Financiado

Cerrado

Feasibility assessment of a cloud application platform for rational drug design...

Feasibility assessment of a cloud application platform for rational drug design using high throughput molecular dynamics The pharmaceutical industry’s increasing spending on R&D is not translating into new and better drugs at the pace required to maintain competitiveness. In-silico computational methods are beginning to gain traction in the progress... ver más

30/11/2015

ACELLERA LABS

71K€

Presupuesto del proyecto: 71K€

Líder del proyecto

ACELLERA LABS Investigacion,diseño,desarrollo,produccion,montaje y comercializacion de productos electronicos e informaticos de toda indole,tanto de softw...

TRL 4-5 | 89K€

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2015-11-30

ICT-37-2014-1: Open Disruptive Innovation Scheme (...

I+D

Cerrada hace 10 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

ACELLERA LABS

50.00K€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

Cloud-HTMD A CLOUD APPLICATION PLATFORM FOR RATIONAL DRUG DISCOVERY USI... 75K€ Cerrado

eDrug Drug eDesign Building the next generation of software solut... 149K€ Cerrado

iEBDD A Software Interface for Interactive Ensemble Based Drug Des... 150K€ Cerrado

ATLAS Next generation HPC/QC in silico drug discovery platform for... 4M€ Cerrado

BINARYBIO Commercialization of distributed cloud solutions for biomo... 137K€ Cerrado

ScalaLife Scalable Software Services for Life Science 4M€ Cerrado

Duración del proyecto: 6 meses Fecha Inicio: 2015-05-28
Fecha Fin: 2015-11-30

Líder del proyecto

ACELLERA LABS Investigacion,diseño,desarrollo,produccion,montaje y comercializacion de productos electronicos e informaticos de toda indole,tanto de softw...

TRL 4-5 | 89K€

Presupuesto del proyecto 71K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The pharmaceutical industry’s increasing spending on R&D is not translating into new and better drugs at the pace required to maintain competitiveness. In-silico computational methods are beginning to gain traction in the progress towards more rational drug discovery workflows. Among the methods available, molecular dynamics (MD) provides the most accurate and useful description of molecular interactions, but the current state of the art has both a high degree of unnecessary technical complexity, and is computationally expensive. Together, these two factors have produced a high barrier to entry that substantially limits research productivity.Acellera looks to address these issues by proposing a cloud application platform for high-throughput MD (HTMD) simulations. This computational platform combines proprietary simulation technology - optimized for speed and simulation throughput – and user-friendly interfaces in a cloud environment to provide a novel resource for drug candidate identification. HTMD, which allows understanding with an unprecedented degree of resolution and accuracy how drugs interact with their biological targets, can significantly reduce the cost of pre-clinical research (PCR) by virtualizing key steps. It is currently estimated that pharmaceutical companies invest approximately 1000M Euro per approved drug. As a global leader in the development of technology for high-throughput molecular dynamics, Acellera is uniquely positioned to bring this disruptive computational technology to the market. The HTMD platform is ready for prototyping in an operational environment (TRL 6). Acellera proposes a Phase 1 SME Instrument to support the execution of a feasibility study into the market viability of the HTMD solution for pre-clinical research. Results of the study will be used to inform preparations for a larger-scale demonstration in Phase 2 and for the subsequent market launch.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores